The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis

Chenyang Wang1, Kyosuke Oishi1, Tadahiro Kobayashi1

  • 1Department of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.

Insights

Toll-like receptor 7 (TLR7) deletion attenuated fibrosis in a systemic sclerosis (SSc) mouse model, reducing inflammation. Conversely, Toll-like receptor 9 (TLR9) deletion exacerbated SSc fibrosis, indicating opposite roles in disease progression.

Area of Science:

  • Immunology
  • Dermatology
  • Fibrosis Research

Background:

  • Systemic sclerosis (SSc) is a complex connective tissue disease with significant immune system involvement.
  • Toll-like receptors (TLRs) are increasingly recognized for their role in inflammatory and fibrotic conditions.
  • The precise roles of TLR7 and TLR9 in SSc pathogenesis remain incompletely understood.

Purpose of the Study:

  • To investigate the specific roles of Toll-like receptor 7 (TLR7) and Toll-like receptor 9 (TLR9) in the immune abnormalities and fibrosis characteristic of systemic sclerosis (SSc).
  • To elucidate the mechanisms by which TLR7 and TLR9 influence the inflammatory and fibrotic processes in a bleomycin-induced mouse model of SSc.

Main Methods:

  • Utilized bleomycin (BLM)-induced scleroderma mouse models with wild-type (WT), TLR7-knockout (TLR7-KO), and TLR9-knockout (TLR9-KO) backgrounds.
  • Employed flow cytometry, RT-PCR, histological examination, and immunohistochemical staining (IHC) to analyze fibrotic and immunological phenotypes.
  • Assessed immune cell populations (pDCs, B cells, T cells, macrophages) and cytokine profiles to evaluate inflammatory and fibrotic responses.

Main Results:

  • TLR7 deficiency significantly attenuated skin and lung fibrosis in the SSc model, accompanied by reduced pro-inflammatory and fibrotic cell/cytokine infiltration.
  • TLR9 deficiency exacerbated skin and lung fibrosis, correlating with an increased infiltration of pro-inflammatory and cytokine-producing cells.
  • TLR7 deletion promoted a shift towards suppressed inflammation and fibrosis, while TLR9 deletion favored inflammation and fibrosis progression, impacting immune cell balances (e.g., Th17/Treg, M1/M2).

Conclusions:

  • TLR7 promotes inflammation and fibrosis progression in the SSc mouse model, suggesting a potential therapeutic target for reducing fibrotic burden.
  • TLR9 exhibits a protective role in SSc, with its deletion worsening fibrotic outcomes, highlighting its complex involvement in immune regulation.
  • TLR7 and TLR9 play opposing roles in the immune system abnormalities and skin fibrosis observed in systemic sclerosis.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
999
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K